A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893-Reference-Cited by-同舟云学术

A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893

Published:2012-10-12 Issue:3 Volume:60 Page:409-414
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Felgenhauer Judy L.,Nieder Michael L.,Krailo Mark D.,Bernstein Mark L.,Henry David W.,Malkin David,Baruchel Sylvain,Chuba Paul J.,Sailer Scott L.,Brown Ken,Ranganathan Sarangarajan,Marina Neyssa

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone;Grier;N Engl J Med,2003

2. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group phase II study 9457-a report from the Children's Oncology Group;Bernstein;J Clin Oncol,2006

3. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group;Cotterill;J Clin Oncol,2000

4. A randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group;Womer;J Clin Oncol

5. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy-a report from the Children's Oncology Group;Miser;Pediatr Blood Cancer,2007

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing for cancer therapy;Signal Transduction and Targeted Therapy;2024-04-19

2. Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application;Seminars in Cancer Biology;2023-10

3. Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board;Cancer;2023-07-05

4. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas;American Society of Clinical Oncology Educational Book;2023-05

5. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents;Pediatric Drugs;2023-04-04